Skip to main content
. Author manuscript; available in PMC: 2015 Oct 15.
Published in final edited form as: Best Pract Res Clin Haematol. 2014 Oct 15;27(0):214–221. doi: 10.1016/j.beha.2014.10.002

Table 2.

Comparison of patients with FANCD1/BRCA2 and other mutations.

Adverse Event FANCD1/BRCA2 Other Genes
By age, years 7 40
Leukemia 50% 20%
Solid Tumor 80% 30%
Any Cancer 97% 50%
Severe bone marrow failure <5% 50%
No adverse event <5% <10%